Breaking Boundaries, Transforming Markets: A Comprehensive Mid-Year Review of the Psychedelic Sector
The first half of 2023 has come to an end, and so far, this year has been just as action-packed as 2022. The first two quarters of the year have been full of first-of-their-kind clinical trials and psychedelic research...
Jul 14, 2023
•
32 min read
Psilocybin
LSD
DMT
MDMA
Ketamine
Ibogaine
Tryptamine
Ayahuasca
Cannabis
Psychedelics